A phase 1 clinical trial to evaluate the safety and pharmacokinetic/pharmacodynamic characteristics of HSG4112 after multiple oral administration in healthy and obese adult subjects : A dose blocked-randomized, double-blind, placebo controlled, multiple dosing, phase I clinical trial to evaluate the safety and pharmacokinetic/pharmacodynamic characteristics of HSG4112 after oral administration in healthy and obese adult subjects
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2022) vom: 20. Sept. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2020-12-23, Last updated: 2022-11-24 |
|---|
| ICTRP ID: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
WHO004981502 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WHO004981502 | ||
| 003 | DE-627 | ||
| 005 | 20230425165032.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210507s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)WHO004981502 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)KCT0005693 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NCT04703764 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a A phase 1 clinical trial to evaluate the safety and pharmacokinetic/pharmacodynamic characteristics of HSG4112 after multiple oral administration in healthy and obese adult subjects |b A dose blocked-randomized, double-blind, placebo controlled, multiple dosing, phase I clinical trial to evaluate the safety and pharmacokinetic/pharmacodynamic characteristics of HSG4112 after oral administration in healthy and obese adult subjects |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2020-12-23, Last updated: 2022-11-24 | ||
| 650 | 4 | |a Medical Condition: ;Endocrine, nutritional and metabolic diseases | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Phase: Phase 1 | |
| 650 | 4 | |a Recruitment Status: Completed | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2022) vom: 20. Sept. |
| 773 | 1 | 8 | |g year:2022 |g day:20 |g month:09 |
| 856 | 4 | 0 | |u https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=22529 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 20 |c 09 | ||